Search

Displaying results 5311 - 5320 of 6949 in total
  1. Drug

    Beta-D-Glucose

    go.drugbank.com/drugs/DB02379
    Investigational

    A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state.

  2. Drug

    Metribolone

    go.drugbank.com/drugs/DB02998
    Experimental

    It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.

  3. Drug

    Azelnidipine

    go.drugbank.com/drugs/DB09230
    Investigational

    It is currently being studied for post-ischemic stroke management [L1380].

  4. Drug

    Fluocinonide

    go.drugbank.com/drugs/DB01047
    ApprovedInvestigational

    A topical glucocorticoid used in the treatment of eczema.

    Categories: Corticosteroid Hormone Receptor Agonists
  5. Drug

    LGD-1550

    go.drugbank.com/drugs/DB05785
    Experimental

    LGD-1550 is an orally-active synthetic aromatic retinoic acid agent with potential antineoplastic and chemopreventive activities.

  6. Drug

    Pristinamycin

    go.drugbank.com/drugs/DB13704
    Investigational

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  7. Drug

    Pagoclone

    go.drugbank.com/drugs/DB04903
    Investigational

    Pagoclone is an anxiolytic drug from the cyclopyrrolone family, which is related to other more well known drugs such as the sleeping medication zopiclone. It is one of a relatively recently developed class of medicines known as the nonbe...

  8. Drug

    R411

    go.drugbank.com/drugs/DB05468
    Experimental

    R411 is a non-steroid oral medicine for the treatment of asthma. It is not immunosuppressive, but blocks the activation and recruitment of cells involved in respiratory inflammation.

  9. Drug

    RGN6024

    go.drugbank.com/drugs/DB33059
    Experimental

    It is designed as an orally administered, blood-brain barrier penetrant therapy for brain cancers, especially glioblastoma. … Reglagene announced FDA orphan drug designation for glioblastoma in 2024. RGN6024 remains investigational and is not an approved drug.

  10. Drug

    Glypromate

    go.drugbank.com/drugs/DB05633
    Experimental

    Neuren Pharmaceuticals was developing Glypromate (glycine-proline glutamate), a naturally occurring small-molecule neuroprotectant derived from IGF-1 which inhibits caspase III dependent apoptosis, for